An Fgf23 bone enhancer, located immediately upstream, was targeted with sgRNAs (targeting CACTGGCTGGGTTCCTGGAG and AGACTTCTTAGGCTTGCGGA) using CRISPR/Cas9 technology, resulting in a 3996 bp deletion. The deleted sequence contains putative CTCF-binding site Rr133122. (J:281531)